Results 21 to 30 of about 1,086,001 (306)
Can We Improve Antifungal Susceptibility Testing?
Frontiers in Cellular and Infection Microbiology, 2021 Systemic antifungal agents are increasingly used for prevention or treatment of invasive fungal infections, whose prognosis remains poor. At the same time, emergence of resistant or even multi-resistant strains is of concern as the antifungal arsenal is ...
C. Durand +5 more
semanticscholar +1 more source
Antimicrobial Agents and Chemotherapy, 2021 Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by genera of melanized fungi: Fonsecaea, Cladophialophora, Phialophora, Exophiala, and Rhinocladiella. Melanin is a virulence factor known to influence antifungal susceptibility.
D. Heidrich +4 more
semanticscholar +1 more source
Journal of Infectious Diseases, 2020 BACKGROUND Candidemia is the most common, serious fungal infection and Candida antifungal resistance is a challenge. We report recent surveillance of candidemia in China. METHODS The study encompassed 77 Chinese hospitals over 3 years.
M. Xiao +19 more
semanticscholar +1 more source
In vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte moulds involved in foot mycosis [PDF]
, 2017 Tinea pedis and onychomycosis are among the commonest fungal diseases in the world. Dermatophytes and, less frequently, non-dermatophyte moulds are aetiological agents of foot mycosis and are capable of forming biofilms.
Bougnoux, Marie Élisabeth +5 more
core +1 more source
Synergistic Antifungal Study of PEGylated Graphene Oxides and Copper Nanoparticles against Candida albicans [PDF]
, 2020 © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).The coupling ...
Arce, Mariana +10 more
core +3 more sources
Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]
, 2017 The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew +6 more
core +4 more sources
Anti-Candida targets and cytotoxicity of casuarinin isolated from Plinia cauliflora leaves in a bioactivity-guided study [PDF]
, 2013 Peer reviewedPublisher ...
Gow, Neil A R +8 more
core +4 more sources
Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus [PDF]
, 2017 This work was supported by Medical Mycology Section, Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Seyedmousavi, Seyedmojtaba +3 more
core +1 more source
Bloodstream yeast infections: a 15-month survey [PDF]
, 2009 A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47.3%) followed by C. glabrata (25.7%), C. parapsilosis (8.0%), C. tropicalis (6.8%) and Saccharomyces cerevisiae (
Detandt, M +3 more
core +1 more source
Antifungal Susceptibilities ofCryptococcus neoformans
Emerging Infectious Diseases, 2004 Resumen Los perfiles de susceptibilidad de los hongos de importancia médica en los países menos desarrollados siguen sin caracterizarse. Medimos las CMI de anfotericina B, 5-flucitosina, fluconazol, itraconazol y ketoconazol para aislados clínicos de Cryptococcus neoformans de Tailandia, Malawi y los Estados Unidos y no encontramos evidencia de ...
Lennox K. Archibald +11 more
openaire +3 more sources